Jennifer Lew Buys 32,000 Shares of BOLD
Insider buying activity sees Jennifer Lew acquiring 32,000 shares of BOLD.
Key Points
- Jennifer Lew acquired 32,000 shares of BOLD on June 15, 2026, at a trading price of $1.41.
- BOLD shares have a 52-week range and a beta that are not disclosed, trading at $1.41.
- Peer institutional activity shows mixed moves, with Citadel Advisors LLC reducing its stake by 11,773 shares.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Jennifer Lew, an insider, bought 32,000 shares of BOLD on June 15, 2026. This transaction highlights ongoing insider interest in the company, with shares trading at $1.41.
Insider Buying and Selling at Boundless Bio, Inc.
Several insiders, including Jennifer Lew, made significant stock purchases on June 15, 2026. Lew, along with James Christensen and Nancy Whiting, each acquired 32,000 shares. Jonathan Lim bought 48,000 shares. Earlier in the year, on January 23, 2026, David Hinkle, Senior VP of Finance, and Zachary Hornby, President & CEO, purchased 140,000 and 600,000 shares respectively.
Other Institutional Activity in BOLD
FMR LLC increased its holdings in BOLD by 11,433 shares, reaching a total of 2,695,455 shares valued at about $2.97 million. Citadel Advisors LLC, however, reduced its position by 11,773 shares, ending with 1,342,131 shares worth approximately $1.48 million. Stonepine Capital Management LLC also cut back significantly, selling 112,389 shares to hold 597,682 shares valued at around $657,450. Meanwhile, Vanguard Capital Management LLC initiated a new position with 597,192 shares valued at about $656,911.
Analysts Set New Price Targets
On August 11, 2025, HC Wainwright & Co. maintained its "buy" rating for BOLD with a price target of $4. Earlier, on June 2, 2025, the firm had initiated coverage with a "buy" rating and a $5 target. Leerink Partners downgraded the stock to "hold" with a $3 target on May 28, 2025, after having previously initiated coverage with a "buy" rating and a $25 target in April 2024.
Bottom Line
Jennifer Lew's purchase of BOLD shares is a notable insider activity, reflecting potential confidence in the company. The stock is trading at $1.41, and while the 13F filings and insider trades provide insight, they may not represent current positions. Investors often track these moves for potential signals about a company’s outlook.
Get Boundless Bio, Inc. alerts
New 13F filings, insider trades, and analyst moves on $BOLD, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.